Another scenario, more applicable to the current case, is that of MMR deficiency resulting from an MMR gene alteration that leads to loss of function but preserved structure or antigenicity of the protein, as has been described in approximately 6% of microsatellite unstable cancers [26]. The gene discussed is MRC1; the disease is cancer.